Bill SYMONDS,Steve PISCITELLI,Karen SEGAL,Ruby HOLDER,Sophie BOZEC,Sebastien BOLZE,Pascale FOUQUERAY,Christophe ARBET-ENGELS,Julie DUBOURG,Paul STRUMPH,Brandon Dale SWIFT,Margaret Smith FLETCHER
申请号：
US16813436
公开号：
US20200215072A1
申请日:
2020.03.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure is directed to a method of treating prediabetes or type 1 or type 2 diabetes mellitus comprising administering to a subject in need thereof an effective amount of imeglimin, wherein the subject has chronic kidney disease.
